Timothy Brewerton to N-Methyl-3,4-methylenedioxyamphetamine
This is a "connection" page, showing publications Timothy Brewerton has written about N-Methyl-3,4-methylenedioxyamphetamine.
Connection Strength
2.193
-
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. J Psychiatr Res. 2022 05; 149:128-135.
Score: 0.810
-
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Med Hypotheses. 2021 Jan; 146:110367.
Score: 0.739
-
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Lancet Psychiatry. 2016 May; 3(5):481-8.
Score: 0.537
-
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013 Jan; 27(1):28-39.
Score: 0.106